Log in to save to my catalogue

Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRN...

Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRN...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2929128760

Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection

About this item

Full title

Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2024-02, Vol.42 (6), p.1332-1341

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Highlights•University testing programs provide an opportunity to estimate vaccine effectiveness in community populations of healthy young adults, a population not well-represented in routine vaccine effectiveness studies. •In a university population, a COVID-19 mRNA monovalent booster dose after primary series provided increased protection against...

Alternative Titles

Full title

Utilizing a university testing program to estimate relative effectiveness of monovalent COVID-19 mRNA booster vaccine versus two-dose primary series against symptomatic SARS-CoV-2 infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2929128760

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2929128760

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2024.01.080

How to access this item